(1)
Design, Synthesis, and Pharmacological Evaluation of Piperazine Hydrazide Derivatives As Potential CNS-Active Antidepressants: MAO-A Inhibition and In Silico Docking Studies on Protein 2BXR and N1 Neuraminidase (PDB 2HU4) for Alzheimer’s Disease . CDF 2025, 54 (2), 1594-1611. https://doi.org/10.48047/CU/54/02/1594-1611.